Alliancebernstein L.P. Innoviva, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Innoviva, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 67,740 shares of INVA stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,740

Previous 70,955 4.53%

Holding current value

$1.21 Million

Previous $1.16 Million 12.38%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $52,500 - $64,428	-3,215 Reduced 4.53%	67,740 $1.31 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $1,440 - $1,639	-100 Reduced 0.14%	70,955 $1.16 Million
Q1 2024 May 14, 2024	SELL	$14.56 - $16.78 $295,276 - $340,298	-20,280 Reduced 22.2%	71,055 $1.08 Million
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $7,453 - $9,843	605 Added 0.67%	91,335 $1.47 Million
Q2 2023 Aug 15, 2023	BUY	$11.39 - $13.72 $335,777 - $404,465	29,480 Added 48.13%	90,730 $1.15 Million
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $99,456 - $126,058	-9,269 Reduced 13.14%	61,250 $689,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $778 - $909	66 Added 0.09%	70,519 $934,000
Q3 2022 Nov 15, 2022	BUY	$11.61 - $15.22 $952 - $1,248	82 Added 0.12%	70,453 $818,000
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $86,106 - $119,538	6,013 Added 9.34%	70,371 $1.04 Million
Q1 2022 May 13, 2022	SELL	$15.39 - $20.25 $640,100 - $842,238	-41,592 Reduced 39.26%	64,358 $1.25 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $219,112 - $257,811	-13,772 Reduced 11.5%	105,950 $1.83 Million
Q3 2021 Nov 10, 2021	SELL	$13.06 - $17.24 $84,746 - $111,870	-6,489 Reduced 5.14%	119,722 $2 Million
Q1 2021 May 06, 2021	SELL	$11.06 - $12.87 $93,866 - $109,227	-8,487 Reduced 6.3%	126,211 $1.51 Million
Q4 2020 Feb 08, 2021	SELL	$9.33 - $12.48 $758,762 - $1.01 Million	-81,325 Reduced 37.65%	134,698 $1.67 Million
Q3 2020 Nov 12, 2020	SELL	$10.33 - $14.49 $344,670 - $483,473	-33,366 Reduced 13.38%	216,023 $2.26 Million
Q2 2020 Aug 13, 2020	BUY	$11.49 - $15.26 $84,991 - $112,878	7,397 Added 3.06%	249,389 $3.49 Million
Q1 2020 May 14, 2020	SELL	$8.11 - $15.23 $40,955 - $76,911	-5,050 Reduced 2.04%	241,992 $2.85 Million
Q4 2019 Feb 18, 2020	BUY	$10.28 - $14.38 $26,728 - $37,388	2,600 Added 1.06%	247,042 $3.5 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $156,780 - $226,980	-15,600 Reduced 6.0%	244,442 $2.58 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $474,220 - $541,190	36,200 Added 16.17%	260,042 $3.79 Million
Q1 2019 May 14, 2019	SELL	$13.69 - $20.06 $45,998 - $67,401	-3,360 Reduced 1.48%	223,842 $3.14 Million
Q4 2018 Feb 13, 2019	SELL	$13.96 - $18.26 $628,060 - $821,517	-44,990 Reduced 16.53%	227,202 $3.97 Million
Q3 2018 Nov 08, 2018	BUY	$13.63 - $15.7 $138,753 - $159,826	10,180 Added 3.89%	272,192 $4.15 Million
Q2 2018 Aug 13, 2018	BUY	$13.44 - $17.59 $240,576 - $314,861	17,900 Added 7.33%	262,012 $3.62 Million
Q1 2018 May 14, 2018	SELL	$13.8 - $16.99 $907,488 - $1.12 Million	-65,760 Reduced 21.22%	244,112 $4.07 Million
Q4 2017 Feb 13, 2018	BUY	$11.73 - $14.75 $197,181 - $247,947	16,810 Added 5.74%	309,872 $4.4 Million
Q3 2017 Nov 13, 2017	BUY	$12.06 - $14.12 $3.53 Million - $4.14 Million	293,062	293,062 $4.14 Million

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Innoviva, Inc. Transaction History